Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
13
×
Tags
detroit blog main
detroit top stories
13
×
national blog main
national top stories
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
indiana blog main
indiana top stories
life sciences
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
fda
clinical trials
cancer
novartis
eli lilly
amgen
crispr
ipo
startups
teva pharmaceutical
venture capital
biogen
bristol-myers squibb
What
new
13
×
bio
drug
roundup
fda
approval
cancer
companies
drugs
ipo
capital
class
crispr
developed
genetic
group
isn’t
known
life
medical
medicine
medicines
migraine
million
raised
remains
science
testing
therapeutics
wave
won
activity
advantages
allogene
amgen
ann
announced
approvals
approved
arbor
Language
unset
Current search:
photo
×
" detroit top stories "
×
new
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
After Scoring New Capital, Fifth Eye Prepares to Seek FDA Approval
@xconomy.com
5 years ago
Bio Roundup: New CRISPR Feud, A NY Splash, Pharma vs. Congress & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
@xconomy.com
6 years ago
Will New Study Cut Guesswork for Depression Medicine Prescriptions?